drugs associated with cancer therapies
TRANSCRIPT
-
8/2/2019 Drugs Associated With CANCER THERAPIES
1/32
Drugs associated with CANCER THERAPIES
OVERVIEW of Antineoplastic Agents
Drugs used to control or kill cancer cells are known as antineoplastic agents.
Also referred to as chemotherapy agents or anticancer drugs.
Because single-agent therapy is unsuccessful in attaining long-term remissions, more than one
agent is used. Also, single-agent therapy produces cell lines resistant to further drug therapies.
Agents of different classes are combined to maximize eachs mode of action. This combining
categories leads to synergistic and additive qualities as well as varied toxicities.
Classes:
1. alkylating agents
2. antimetabolites
3. antitumor antibiotics
4. plant or Vinca alkaloids
5. Other antineoplastic agents
Other antineoplastic agents
Miscellaneous Agents have a mechanism of action that is different from other classifications or is
not fully understood. These agents are cell nonspecific. They also produce major toxicities to
hematopoeitic system and anaphylaxis. Include Aminoglutethimide (Elipten), L- asparaginase
(Elspar), Mitoxantrrone (Novantrone), and procarbazine hydrochloride(Matulane).
Investigational Agents are those currently undergoing clinical trials and are not yet approved by the
Food and Drug Administration. These agents include new drugs and previously approved drugs
whose original approval is now being administered in a different manner, combination or disease.
Some cancer clients choose treatment with an investigational agent or protocol.
Action:
Antineoplastic agents destroy cells in their growth phase. They may be Cell cycle specific or
nonspecific.
Cell cycle specific produce cytotoxic effects in a particular phase of the cells reproductive cycle
(G1-M) and are effective in tumors with rapidly dividing cells.
Cell cycle non specific agents are effective in any phase of the cell cycle (including Go-resting
phase and are most effective against slow growing tumors.
anticancer drugs:
-
8/2/2019 Drugs Associated With CANCER THERAPIES
2/32
Cell cycle= growth and division
Cell cycle
18_01_cel l_cycle . jpg
-
8/2/2019 Drugs Associated With CANCER THERAPIES
3/32
Effects of chemotherapeutic drugs on cell cycle
As applied:
Cell cycle specific drugs (CCS) or phase specific :
Antimetabolites: Methotrexate, 6-Mercaptopurine
Antibiotic: Bleomycin
Taxane: Paclitaxel
Epipodophyllotoxins: Etoposide, Teniposide
Vinca alkaloids: Vinblastine, Vincristine
Act mainly on dividing cells
Most effective in hematologic and solid tumors with high growth fraction
-
8/2/2019 Drugs Associated With CANCER THERAPIES
4/32
Cell cycle non-specific (CCNS) or phase non specific drugs:
Alkylating agents: Cyclophosphamide, Busulfan, Mechlorethamine, Melphalan.
Anticancer antibiotics: Doxorubicin, Daunorubicin, Mitomycin, Actinomycin D.
Camptothecins: Topotecan, Irinotecan
Metal complexes: Cisplatin, Carboplatin
CCNS drugs act on dividing as well as resting cells
Effective in low growth fraction as well as high growth fraction solid tumors
Characteristics of Cancer Cells
The problem:
Cancer cells divide rapidly (cell cycle is accelerated)
They are immortal
Cell-cell communication is altered
uncontrolled proliferation
invasiveness
Ability to metastasize
The Goal of Cancer Treatments
Curative
Total irradication of cancer cells
Curable cancers include testicular tumors, Wills tumor
Palliative
Alleviation of symptoms
Avoidance of life-threatening toxicity
Increased survival and improved quality of life
Adjuvant therapy
Attempt to eradicate microscopic cancer after surgery
e.g. breast cancer & colorectal cancer
Six Established Rx Modalities
-
8/2/2019 Drugs Associated With CANCER THERAPIES
5/32
1. Surgery
2. Radiotherapy
3. Chemotherapy
4. Endocrine therapy
5. Immunotherapy
6. Biological therapy
What is a neoplasm?
Cells with an abnormal growth pattern
Either benign or malignant
Any overgrowth of tissue can form a tumor
Benign neoplasm
Composed of cells that look like the tissue of origin
Usually encapsulated
Grow slowly and by expansion
Do not recur or metastasize
Do not destroy tissue generally
Do not cause systemic symptoms or death generally
Malignant neoplasm
Composed of undifferentiated (or immature) cells.
Little resembles the tissue of origin
Grows rapidly
Expands at periphery and invades and destroys surrounding tissue
Recurs and metastasizes to other parts of the body
Spreads by way of lymph and blood to distant parts of the body
Causes systemic signs and symptoms
Ultimately, it can cause death
What makes a cancer able to metastasize?
-
8/2/2019 Drugs Associated With CANCER THERAPIES
6/32
Can be spread by blood/lymph system
This helps us predict what organs will be metastasized
Spread by direct contact organ to organ
Iatrogenic spread: surgical seeding or invasive procedure moving cells from one site to another
Oncogenes and Proto-oncogenes
Genes capable of triggering cancerous conditions
Normally suppressed
Can be triggered by invading viruses or other carcinogens
Proto-oncogenes: benign forms of oncogenes necessary of normal function
Fragile and easily damaged and mutated
Immune response
Immune response failure
When the immune system is compromised it fails to.
Suppress oncogenes
Kill off the cancerous cells that normally form within the body
Normal cell cycle becomes deranged
Damage occurs to the DNA and proteins inside the cell
Immunological defects
If the immunological system is not working:
The body is more susceptible to invasion by foreign agents, cancer included
People with immunological disorders are at higher risk for developing certain kinds of
malignant disorders
Persons with AIDS
Persons receiving immunosuppressive therapy for neoplastic or non-neoplastic
disorders
Biological Carcinogens
Viruses
HIV, HBV, papilloma viruses, HTLV
-
8/2/2019 Drugs Associated With CANCER THERAPIES
7/32
Genetics
The etiology of cancer is unknown
It is generally assumed that genetic factors are involved
Chemical Carcinogens
Drugs and hormones
Chemotherapeutic drugs
Recreational drugs
DES, estrogen, cortisone, anabolic steroids
Diet
Alcohol
Carcinogens
Chemical agents:
Industrial wastes, pesticides, cigarette smoke, asbestos, phenol
Natural body substances in body: bile acids
Food additives: sodium saccharine, nitrites
Physical agents
Radiation (both solar and ionizing), and radon, nuclear radiation
Risk factors for cancer
Non-controllable
Heredity, age, gender, and poverty
Controllable
Stress, diet, occupation, infection, tobacco use, alcohol use, use of recreational drugs,
obesity, and sun exposure
Types of malignant neoplasms
Solid cancers (Tumors)
Carcinoma: arises in epithelial cells
Sarcoma: arises in connective tissue, muscle, or bone
-
8/2/2019 Drugs Associated With CANCER THERAPIES
8/32
Hematological cancers
Leukemia: arises in blood
Myeloma: arises in bone marrow
Lymphoma: arises in lymph tissue
Clinical staging for surgery
Reveals the extent of cancer spread
By sampling regional and distant lymph nodes
By sampling and viewing other organs for tumors
(an example: is the removal of axillary lymph nodes during surgery for breast cancer)
Grading and staging
Once cancer diagnosis is made, the tumor is graded and staged
Grading: evaluates the amount of differentiation of the cancer cells
Grade 1 (the least malignant) to grade 4 (the most malignant)
Grade 1 is the most differentiated and Grade 4 is the least differentiated
Staging: refers to the relative tumor size and extent of the disease
A tumor in situ is stage 0, while a stage 4 indicates widespread metastasis
TNM Staging of Cancer
Based on the following:
(T) relative tumor size
(N) presence and extent of lymph node involvement
(M) distant metastases
Signs and Symptoms of Cancer
C(change in bowel or bladder habits)
A (a sore that doesnt heal)
U(Unusual bleeding or discharge)
T (thickening or lump in tissue)
I (indigestion or difficulty swallowing)
-
8/2/2019 Drugs Associated With CANCER THERAPIES
9/32
O (obvious change in wart or mole)
N(nagging cough or hoarseness)
U Unexplained anemia
S sudden unexplained weight loss
Collaborative Management
Most treatments for cancer will require collaboration with multiple health care providers (HCPs)
Collaborative, outcome driven planning is essential to provide the best care with the least negative
impact upon the client and family
Diagnosis of Cancer
Can only be made with a biopsy
Types of biopsys:
Needle biopsy
Incisional biopsy
Excisional biopsy
Diagnostic studies
Radiological testing
X-rays
CTs
Ultrasounds
MRIs
Can only locate and visualize a mass or tumor, cannot make the determination of
malignancy
Diagnostic studies
Direct visualization
Sigmoidoscopy
Cystoscopy
Endoscopy
Bronchoscopy
-
8/2/2019 Drugs Associated With CANCER THERAPIES
10/32
Exploratory surgery
Laboratory tests
Tumor markers
Oncofetal antigens
Hormones
Tissue specific proteins
Isoenzymes
Biopsy
The only way to be certain of malignancy
The visualization of changed cells microscopically
Other blood tests
Leukemias are generally suspected when there is a blood smear that contains immature forms of
leukocytes, which is often combined with low blood counts
Surgical Interventions
Was once the only treatment available
Still is used in diagnosis and staging of more than 90% of all tumors and as primary treatment in
more than 60% of tumors
May be:
Curative (complete removal)
Palliative (decreases symptoms)
Adjunctive (debulking tumor so that radiation and chemo can work)
reconstructive
Radiation Therapy
Treatment of choice for some tumors
Can be used to:
Kill tumor cells to cure cancer
Reduce the size of a tumor
Decrease pain
-
8/2/2019 Drugs Associated With CANCER THERAPIES
11/32
Relieve an obstruction
Reduce chance of metastasis, if just beginning
How it works
Radiation provides lethal injury to the DNA of the cell
It affects rapidly growing cells, like tumor cells
It also affects normal cells that are growing rapidly
The goal is to achieve maximum tumor control with minimum damage to normal tissue
External Radiation
Source of radiation comes from a machine which emits a relatively uniform dosage of radiation to
all tissues selected for radiation.
Internal radiation
Brachytherapy
Implant (wires, tubes, capsules, rods, etc) placed by a surgeon or oncologist. Usually is
temporary
Can be ingested or injected into the clients blood stream or a body cavity
Is a risk to those who are in contact with the patient. The radiation is transmitted outside
the body
Brachytherapy safety considerations
Maintain the greatest possible distance from the patient
Spend the minimum amount of time with the patient
Use lead gloves and aprons as a shield when possible
Keep pregnant people away
Avoid direct contact with radioisotope containers
Brachytherapy safety considerations
People working with these people a lot must wear a radiation monitor badge to track exposure level
to radiation
Patients should be in a private room with a private bathroom
Dispose of bodily wastes according to facility policy
Handle linens according to facility policy
-
8/2/2019 Drugs Associated With CANCER THERAPIES
12/32
Chemotherapy
The use of cytotoxic medications and chemicals to
Cure some cancers
Decrease tumor size (as an adjunct to surgery or radiation therapies)
Prevent or treat suspected metastases
How chemo works
It disrupts the cell cycle in various phases by interrupting cell metabolism and replication
It interferes with the ability of the cell to synthesize needed enzymes and chemicals
It is generally given in specific combinations of drugs to affect malignant cells at their most
vulnerable times
Types of Chemo drugs
Alkylating agents
Antimetabolics
Cytotoxic antibiotics
Plant alkaloids (two types)
Vinca alkaloids
Etopsodes
Hormone and hormone antagonists
Miscellaneous drugs
Preparation and administration
Some medications are oral or IM, but many are given IV. Very irritating, if infiltrated, stop infusion
immediately.
Most states require special certification and education to administer chemo drugs.
These drugs are potentially carcinogenic and corrosive. Follow policies regarding spills.
Safety for the nurse
Wear gloves, mask and gown for administration and work in a quiet area in a methodical manner
Spills can be very hazardous
Follow special spill policies and procedures
-
8/2/2019 Drugs Associated With CANCER THERAPIES
13/32
Special equipment for spills available
Nurses should be aware of drugs being given and how to handle client body wastes.
Toxicity
Watch for bone marrow suppression
Watch for infection
Watch for organ toxicity(GI tract, liver, cardiac, pulmonary, urinary, neurological)
Watch for anaphylaxis
Nausea and vomiting
Give antiemetics 30-45 minutes prior to treatments
Give antiemetics on a round the clock schedule if N/V is severe
Use relaxation, therapeutic touch, diversion with music, etc..
Avoid foods, smells, etcthat induce nausea
General Nursing Diagnosis
Anxiety/powerlessness
Body image disturbance
Anticipatory grieving
Risk for infection/injury
Altered nutrition
Pain
fatigue
Impaired tissue integrity
Caregiver role strain
Ineffective individual/family coping
Altered role
Fluid volume disturbance
And many more
Immunotherapy
-
8/2/2019 Drugs Associated With CANCER THERAPIES
14/32
Biologic response modifiers
Designed to enhance the clients own immune response
Can consist of the administration of interleukin or interferon
Other kinds of immunotherapy are monoclonal antibodies and hematopoietic growth factors
Bone marrow and stem cell transplantation
Most commonly used for leukemia's, now also for some solid mass tumors, such as breast cancers
Stem cell transplantation
Harvesting from pheresis
Cord blood stem cells
Unproven methods of cancer treatment
Chemicals and drugs
Nutrition
Occult techniques
Mechanical devices
Supportive care
Divine healing
Psychologic Stressors
Death sentence
Guilt
Anger
Fear
Powerlessness
Body image disturbance
Sexual dysfunction concerns
Infection
Tumor itself may cause fistula between two incompatible organs (e.g. bowel and bladder)
Tumor may erode through to the surface causing an open lesion
-
8/2/2019 Drugs Associated With CANCER THERAPIES
15/32
Tumor may destroy the tissues that feed it and then become necrotic causing septicemia
Immune system impairment
Pain
One of the most serious concerns of clients and families because of the reputation of being difficultto control
Causes of cancer pain
Due to direct tumor involvement
Due to the treatments
Due to a cause not related to the cancer or the therapy
Nursing Care of the Client with Cancer
Effects of Cancer
1. Disturbed or loss of physiologic functioning, from pressure or obstruction
a. Anoxia and necrosis of organs
b. Loss of function: bowel or bladder obstruction
c. Increased intracranial pressure
d. Interrupted vascular/venous blockage
e. Ascites
f. Disturbed liver functioning
2. Hematologic Alterations: Impaired function of blood cells
a. Abnormal wbcs: impaired immunity
b. Diminished rbcs and platelets: anemia and clotting disorders
3. Infections: fistula development and tumors may become necrotic; erode skin surface
4. Hemorrhage: tumor erosion, bleeding, severe anemia
5. Anorexia-Cachexia Syndrome: wasting away of client
a. Unexplained rapid weight loss, anorexia with altered smell and taste
b. Catabolic state: use of bodys tissues and muscle proteins to support cancer cell growth
6. Paraneoplastic Syndromes: ectopic sites with excess hormone production
-
8/2/2019 Drugs Associated With CANCER THERAPIES
16/32
a. Parathyroid hormone (hypercalcemia)
b. Ectopic secretion of insulin (hypoglycemia)
c. Antidiuretic hormone (ADH: fluid retention)
d. Adrenocorticotropic hormone (ACTH)
7. Pain: major concern of clients and families associated with cancer
a. Types of cancer pain
1. Acute: symptom that led to diagnosis
2. Chronic: may be related to treatment or to progression of disease
b. Causes of pain
1. Direct tumor involvement including metastatic pain
2. Nerve compression
3. Involvement of visceral organs
8. Physical Stress: body tries to respond and destroy neoplasm
a. Fatigue
b. Weight loss
c. Anemia
d. Dehydration
e. Electrolyte imbalances
9. Psychological Stress
a. Cancer equals death sentence
b. Guilt from poor health habits
c. Fear of pain, suffering, death
d. Stigmatized
Collaborative Care
A. Diagnostic Tests: used to diagnose cancer
1. Determine location of cancer
-
8/2/2019 Drugs Associated With CANCER THERAPIES
17/32
a. Xrays
b. Computed tomography
c. Ultrasounds
d. Magnetic resonance imaging
e. Nuclear imaging
f. Angiography
2. Diagnosis of cellular type of can be done through tissue samples from biopsies, shedded cells (e.g.
Papanicolaou smear) washings
a. Cytologic Examination: tissue examined under microscope
b. Identification System of Tumors: Classification Grading -- Staging
1. Classification: according to the tissue or cell of origin, e.g. sarcoma, from supportive
2. Grading:
a. Evaluates degree of differentiation and rate of growth
b. Grade 1 (least aggressive) to Grade 4 (most aggressive)
3. Staging
a. Relative tumor size and extent of disease
b. TNM (Tumor size; Nodes: lymph node involvement; Metastases)
3. Tumor markers: specific proteins which indicate malignancy
a. PSA (Prostatic-specific antigen): prostate cancer
b. CEA (Carcinoembryonic antigen): colon cancer
c. Alkaline Phosphatase: bone metastasis
4 Direct Visualization
a. Sigmoidoscopy
b. Cystoscopy
c. Endoscopy
d. Bronchoscopy
e. Exploratory surgery; lymph node biopsies to determine metastases
-
8/2/2019 Drugs Associated With CANCER THERAPIES
18/32
Other non-specific tests
a. CBC, Differential
b. Electrolytes
c. Blood Chemistries: (liver enzymes: alanine aminotransferase (ALT); aspartateaminotransferase (AST) lactic dehydrogenase (LDH)
Treatment Goals: depending on type and stage of cancer
A. Cure
1. Recover from specific cancer with treatment
2. Alert for reoccurrence
3. May involve rehabilitation with physical and occupational therapy
4. Three Seasons of survival
a. Diagnosis/treatment
b. Extended survival: treatment completed and watchful waiting
c. Permanent survival: risk of recurrence is small
B. Control: of symptoms and progression of cancer
1. Continued surveillance
2. Treatment when indicated (e.g. some bladder cancer, prostate cancer)
C. Palliation of symptoms: may involve terminal care if clients cancer is not responding to treatment
Treatment Options (depend on type of cancer) alone or with combination
A. Chemotherapy
1. Chemotherapy
a. Includes phase-specific and non-phase specific drugs for specific cancer types
b. Often combinations of drugs in specific protocols over varying time periods
c. Cell-kill hypothesis: with each cell cycle a percentage of cancerous cells are killed but
some remain; repeating chemo kills more cells until those left can be handled by bodys immune
system
2. Classes of Chemotherapy Drugs
a. Alkylating agents
-
8/2/2019 Drugs Associated With CANCER THERAPIES
19/32
1. Action: create defects in tumor DNA
2. Examples: Nitrogen Mustard, Cisplatin
b. Antimetabolites
1. Action: specific for S phase
2. Examples: Methotrexate; 5 fluorouracil
3. Toxic Effects: nausea, vomiting, stomatitis, diarrhea, alopecia, leukopenia
c. Antitumor Antibiotics
1. Action: non-phase specific; interfere with DNA
2. Examples: Actinomycin D, Bleomycin
3. Toxic Effect: damage to cardiac muscle
d. Miotic inhibitors
1. Action: Prevent cell division during M phase
2. Examples: Vincristine, Vinblastine
3. Toxic Effects: affects neurotransmission, alopecia, bone marrow depression
e. Hormones
1. Action: stage specific G1
2. Example: Corticosteroids
f. Hormone Antagonist
1. Action: block hormones on hormone-binding tumors (breast, prostate, endometrium; cause
tumor regression
2. Examples: Tamoxifen (breast); Flutamide (prostate)
3. Toxic Effects: altered secondary sex characteristics
Effects of Chemotherapy
a. Tissues (fast growing) frequently affected
b. Examples: mucous membranes, hair cells, bone marrow, specific organs with specific
agents, reproductive organs (all fetal toxic, impair ability to reproduce)
4. Administration of chemotherapeutic agents
a. Trained and certified personnel, according to established guidelines
-
8/2/2019 Drugs Associated With CANCER THERAPIES
20/32
b. Preparation
1. Protect personnel from toxic effects
2. Extreme care for correct dosage; double check with physician orders, pharmacists
preparation
c. Proper management clients excretement
d. Routes
1. Oral
2. Body cavity (intraperitoneal or intrapleural)
3. Intravenous
a. Use of vascular access devices because of threat of extravasation (leakage into tissues) and long-
term therapy
b. Types of vascular access devices
1. PICC lines (peripherally inserted central catheters)
2. Tunnelled catheters (Hickman, Groshong)
3. Surgically implanted ports (accessed with 90o angle needle)
Nursing care of clients receiving chemotherapy
1. Assess and manage
a. Toxic effects of drugs (report to physician)
b. Side effects of drugs: manage nausea and vomiting, inflammation and ulceration of
mucous membranes, hair loss, anorexia, nausea and vomiting with specific nursing and medical
interventions
2. Monitor lab results (drugs withheld if blood counts seriously low); blood and blood product
administration
3. Assess for dehydration, oncologic emergencies
4. Teach regarding fatigue, immunosuppression precautions
5. Provide emotional and spiritual support to clients and families
B. Surgery
1. Diagnosis, staging, and sometimes treatment of cancer
2. Involves removal of body part, organ, sometimes with altered functioning (e.g. colostomy)
3. Debulking (decrease size of) tumors in advanced cases
-
8/2/2019 Drugs Associated With CANCER THERAPIES
21/32
4. Reconstruction and rehabilitation (e.g. breast implant post mastectomy)
5. Psychological support to deal with surgery as well as cancer diagnosis
C. Radiation Therapy
1. Treatment of choice for some tumors to kill or reduce tumor, relieve pain or obstruction
2. Delivery
a. Teletherapy (external): radiation delivered in uniform dose to tumor
b. Brachytherapy: delivers high dose to tumor and less to other tissues; radiation source is
placed in tumor or next to it
c. Combination
3. Goals
a. Maximum tumor control with minimal damage to normal tissues
b. Caregivers must protect selves by using shields, distancing and limiting time with client,
following safety protocols
4. Treatment Schedules
a. Planned according to radiosensitivity of tumor, tolerance of client
b. Monitor blood cell counts
5. Side Effects
a. Skin (external radiation): blanching, erythema, sloughing
b. Ulcerated mucous membranes: pain, lack of saliva
c. Gastrointestinal: nausea and vomiting, diarrhea, bleeding, sometimes fistula formation
d. Radiation pneumonia
D. Biotherapy
1. Modification of biologic processes that result in malignancies; based on immune
surveillance hypothesis
2. Used for hematological malignancies, renal and melanoma
3. Monoclonal antibodies (inoculate animal with tumor antigen and retrieve antibodies against
tumor for human)
E. Photodynamic Therapy
1. Client giving photosensitizing compound which concentrates in malignant tissue
-
8/2/2019 Drugs Associated With CANCER THERAPIES
22/32
2. Later given laser treatment to destroy tumor
F. Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation
1. Stimulation of nonfunctioning marrow or replace bone marrow
2. Common treatment for leukemias
G. Pain Control
1. Includes pain directly from cancer, treatment, or unrelated
2. Necessary for continuing function or comfort in terminally ill clients
3. Goal is maximum relief with minimal side effects
4. Multiple combinations of analgesics (narcotic and non-narcotic) and adjuvants such as
steroids or antidepressants; includes around the clock (ATC) schedule with additional medications
for break-through pain
5. Multiple routes of medications
6. May involve injections of anesthetics into nerve, surgical severing of nerves radiation
7. May need to progress to stronger pain medications as pain increases and client develops
tolerance to pain medication
Nursing Diagnoses for Clients with Cancer
A. Anxiety
1. Therapeutic interactions with client and family; community resources such as AmericanCancer Society, I Can Cope
2. Availability of community resources for terminally ill (Hospice care in-patient, home care)
B. Disturbed Body Image
1. Includes loss of body parts (e.g. amputations); appearance changes (skin, hair); altered
functions (e.g. colostomy); cachexic appearance, loss of energy, ability to be productive
2. Fear of rejection, stigma
C. Anticipatory Grieving
1. Facing death and making preparations for death: will be consideration
2. Offer realistic hope that cancer treatment may be successful
D. Risk for Infection
E. Risk for Injury
-
8/2/2019 Drugs Associated With CANCER THERAPIES
23/32
1. Organ obstruction
2. Pathological fractures
F. Altered Nutrition: less than body requirements
1. Consultation with dietician, lab evaluation of nutritional status
2. Managing problems with eating: anorexia, nausea and vomiting
3. May involve use of parenteral nutrition
G. Impaired Tissue Integrity
1. Oral, pharyngeal, esophageal tissues (due to chemotherapy, bleeding due to low platelet counts,
fungal infections such as thrush)
2. Teach inspection, frequent oral hygiene, specific non-irritating products, thrush control
Oncologic Emergencies
A. Pericaridal Effusion and Neoplastic Cardiac Tamponade
1. Concern: compression of heart by fluid in pericardial sac, compromised cardiac output
2. Treatment: pericardiocentesis
B. Superior Vena Cava Syndrome
1. Concern: obstruction of venous system with increased venous pressure and stasis; facial
and neck edema with slow progression to respiration distress
2. Treatment: respiratory support; decrease tumor size with radiation or chemotherapy
C. Sepsis and Septic Shock
1. Concern: Early recognition of infection
2. Treatment: prompt
D.Spinal Cord Compression
1. Concern: pressure from expanding tumor can cause irreversible paraplegia; back pain
initial symptom with progressive paresthesia and leg pain and weakness
2. Treatment: early detection and radiation or surgical decompression
E. Obstructive Uropathy
1. Concern: blockage of urine flow; undiagnosed can result in renal failure
2. Treatment: restore urine flow
-
8/2/2019 Drugs Associated With CANCER THERAPIES
24/32
F. Hypercalcemia
1. Concern: high calcium from ectopic parathyroid hormone or metastases
2. Behaviors: fatigue, muscle weakness, polyuria, constipation progressing to coma, seizures
3. Treatment: restore fluids with intravenous saline; loop diuretics; more definitive treatments
G. Hyperuricemia
1. Concern: occurs with rapid necrosis of tumor cells as with chemotherapy; can result in
renal damage and failure
2. Prevention and treatment with fluids and Alopurinol (Zyloprim)
H. SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion)
1. Concern: ectopic ADH production from tumor leads to excessive hyponatremia
2. Treatment: restore sodium level
Chemotherapy is the use of chemicals to treat disease. Paul Erlich, considered to be the father of
chemotherapy, coined this word to describe a specific chemical utilized in the treatment of parasites. Today
the term chemotherapywhile technically describing drug therapy for any disease , is most frequently used
in reference to the treatment of cancer. The simple definition of chemotherapy, although accurate , fails to
encompass its multifaceted nature which is as complex as the disease it attempts to treat.
Just as the word cancer represents many different types of malignant disease, the word chemotherapy
represents many different types of chemotherapeutic agents. The drugs used in cancer treatment vary in
their chemical structure , biological side effects and toxicities. Some are effective in treating one specific
types of cancer while others are utilized in the treatment of wide variety of malignancies. The methods of
administration also vary according to the chemotherapeutic and new techniques for safer and moreeffective administration.
The process of learning about chemotherapy is indeed a challenge. Nursing management of the patient
receiving chemotherapy requires knowledge about the treatment , skill in assessment, technical expertise,
ability and desire to support the client physically and emotionally. The reward in meeting this is to be able to
provide the care this clients need in order to survive their disease and its treatment and hopefully to go on
with their lives with as few physical and emotional scars as possible.
Nursing care begins with a thorough understanding of the patients condition; goal of therapy , drug dose,
route, schedule, administration principles; and potential side effects. Additional nursing management
includes monitoring responses to the therapy, reassessing and documenting signs and symptoms, and
communicating pertinent information to other members of the health care team.
Chemotherapy is the use of cytotoxic drugs in the treatment of cancer. It is one of the four modalities-
surgery, radiation therapy, chemotherapy and biotherapy- that provide cure, control, or palliation.
Chemotherapy is systemic as opposed to localized therapy such as surgery & radiation therapy.
There are four ways chemotherapy may be used:
1. Adjuvant therapy- A course of chemotherapy used in conjunction with another treatment modality.
2. Neoadjuvant chemotherapy- Administration of chemotherapy to shrink the tumor prior to surgical
-
8/2/2019 Drugs Associated With CANCER THERAPIES
25/32
removal of the tumor.
3. Primary therapy- The treatment of patients with localized cancer for which there is an alternative
but less than completely effective treatment.
4. Induction chemotherapy- The drug therapy is given as the primary treatment for patients with
cancer for which no alternative treatment exists.
5. Combination chemotherapy- Administration of two or more chemotherapeutic agents in the
treatment of cancer, allowing each medication to enhance the action of the other or act synergistically with
it. e.g. MOPP regimen for Hodgkins disease.
ROLE OF A NURSE
Prior to chemotherapy administration
1 Review- The chemotherapy drugs prescription which should have
-Name of anti-neoplastic agent.
-Dosage
-Route of administration
-Date and time that each agent to be administered.
2. Accurately identify the client
3.Medications to be administered in conjunction with the chemotherapy e.g antiemetics, sedatives etc.
4.. Assess the clients condition including
- Most recent report of blood counts including hemoglobin ,hematocrit, white blood cells and platelets.
-Presence of any complicating condition which could contraindicate chemotherapeutic agent
administration i.e. infection, severe stomatitis , decreased deep tendon reflexes, or bleeding .
-Physical status
-Level of anxiety
-Psychological status.
5. Prepare for potential complications
Review the policy and have medication and supplies available for immediate intervention the event of
extravasation.
Review the procedure and have medication available for possible anaphylaxis
6.Assure accurate preparation of the agent
-Accuracy of dosage calculation
-Expiry date of the drug to be checked
-Procedure for correct reconstitution and
-Recommended procedures for administration
7.Assess patients understanding of the chemotherapeutic agents and administration procedures.
II. Calculation of drug dosage
It is calculated based on body surface area.
III. Drug reconstitution/Preparation- Pharmacy staff should reconstitute all drugs pre-prime the
intravenous tubing under a class II biologic safety cabinet(BSC). In certain conditions nurses may be
required to reconstitute medications. When preparing and reconstituting safe handling guidelines to be
followed.
-All chemotherapeutic drug should be prepared according to package insert in class II BSC.
-Aseptic technique should be followed.
-Personal protective equipment includes disposable surgical gloves, long sleeves gown and elastic or knit
-
8/2/2019 Drugs Associated With CANCER THERAPIES
26/32
cuffs.
-Protective eye goggles if no BSC
-To minimize exposure
-Wash hands before and after drug handling.
-Limit access to drug preparation area
-Keep labeled drug spill kit near preparation area.
-Apply gloves before drug handling.
-Open drug vials/ ampoules away from body.
-Place absorbent pad on work surface.
-Wrap alcohol wipe around neck of ampoule before opening.
-Cover tip of needle with sterilize gauge when expelling air from syringe.
-Label all chemotherapeutic drugs.
Clean up any spill immediately
IV. Drug administration
1. Route-
i)Oral - Emphasize the importance of compliance by the patient with prescribed schedule.Drugs with
emetic potential should be taken with meals.
Assure that chemotherapeutic agents are stored as directed by the manufacturer(refrigerate, avoid
exposure to direct light,etc).
ii) Intramuscular and subcutaenous Chemotherapeutic agents that can be administered I/M or
subcutaneously are few in number. Non-vesicants like L-asperaginase, bleomycin, cyclophosphamide,
methotraxate. Cyta arabine,and some hormonal agents are given I/M & /Or subcutaneously.
Use the smallest gauge needle possible for the viscosity of the medication.
-Change the needle after withdrawing the agent from a vial or ampoule.
-Select a site with adequate muscle and/or SC tissue.
iii) Intravenous It is the most common method of administration of cancer chemotherapy. May be given
through central venous catheters or peripheral access. Absorption is more reliable. This route is required
for administration of vesicants and it also reduces the need of repeated injection. Because the I/V provides
direct access to the circulatory system, the potential for infection and life threatening sepsis is a serious
complication of I/V chemotherapy.
The following guidelines to be kept in mind:
-Inspect the solution, container and tubing for signs of contamination including particles, discoloration,
cloudiness, and cracks or tears in bottle or bag
-Aseptic technique to be followed
-Prepare medicines according to manufacturers directions
-Select a suitable vein
-Large veins on the forearm are the preferred site.
-Use distal veins first, and choose a vein above areas of flexion.
-For non-vesicant drugs, use the distal veins of the hands (metacarpal veins): then the veins of the
forearms(basilic and cephalic veins)For vesicants, use only the veins of the forearms. Avoid using the
metacarpal and radial areas.
-Avoid the antecubital fossa and the wrist because an extravasation in these areas can destroy
nerves and tendons, resulting in loss of function.
-Peripheral sites should be changed daily before administration of vesicants
-
8/2/2019 Drugs Associated With CANCER THERAPIES
27/32
-Avoid the use of small lumen veins to prevent damage due to friction and the decreased ability to dilute
acidic drugs and solutions. Select the shortest catheter with the smallest gauge appropriate for the type and
duration of the infusion (21g to 25g for I/V medications and 19 g for blood products).
Avoid a vein which has been used for venous access within the past 24 hrs to prevent leakage from a prior
puncture site.
Prevent trauma and infection at the insertion site.-Apply a small amount of iodine based antiseptic ointment over the insertion site & cover the area
with sterile gauze.
Intravenous Chemotherapy Via Central Vein Infusion (Hickman Catheter)
A Hickman catheter is a flexible polymeric silicon rubber catheter which is threaded through the cephalic
vein and into the superior vena cava or through the venacava and into the right atrium of the heart.
Placement in a large vein permits the use of a catheter large enough for infusion of chemotherapy, hyper
osmolar fluids for nutrition purposes, blood products and other needed intravenous fluids.
The silicon rubber material of catheter is chemically inert to prevent decomposition and it is anti-
thrombogenic
A felt cuff near the exit site anchors the catheter on the patients chest and acts as an anatomic barrier toprevent entry of infection causing agents.
It is either single lumen or double-lumen.
IV) Intra-arterial
V)Intra-peritoneal
VI)Intrathecal- Infusion of medication can be given through an Ommaya reservoir, implantable pump
and /or usually through lumbar puncture.
a)Wear protective equipment (gloves, gown and eyewear).
b)Inform the patient that chemotherapeutic drugs are harmful to normal cells and that protective
measures used by personnel minimize their exposure to these drugs.
c)Administer drugs in a safe and unhurried environment.
d)Place a plastic backed absorbent pad under the tubing during administration to catch any leakage.
Do not dispose of any supplies or unused drugs in patient care areas.
V. Documentation
Record
-chemotherapeutic drugs, dose, route ,and time
-Premedications, postmedications, prehydration and other infusions and supplies used for chemotherapy
regimen.
-Any complaints by the patient of discomfort and symptoms experienced before, during, and after
chemotherapeutic infusion.
VI. Disposal of supplies and unused drugs
a)Do not clip or recap needles or break syringes.
b)Place all supplies used intact in a leak proof ,puncture proof, appropriate labeled
container.
c)Place all unused drugs in containers in a leak proof, puncture proof, appropriately labeled
container.
d)Dispose of containers filled with chemotherapeutic supplies and unused
drugs in accordance with regulations of hazardous wastes.
-
8/2/2019 Drugs Associated With CANCER THERAPIES
28/32
VII. Management of chemotherapeutic spills
Chemotherapy spills should be cleaned up immediately by properly protected personnel trained in the
appropriate procedure. A spill should be identified with a warning sign so that other person will not be
contaminated.
Supplies RequiredChemotherapy spill kit contains
Respirator mask for air borne powder spills
Plastic safety glasses or goggles
Heavy duty rubber gloves
Absorbent pads to contain liquid spills
Absorbent towels for clean up after spills
Small scoop to collect glass fragments
Two large waste disposal bags
Protective disposable gown
Containers of detergent solution and clear tap water for post spill clean up.
Puncture proof and leak proof container approved for chemotherapy waste disposal
Approved, specially labeled, impervious laundry bag.
Spill on hard surface
Restrict area of spill
Obtain drug spill kit
Put on protective gown, gloves, goggles
Open waste disposal bags
Place absorbent pads gently on the spill; be careful not to touch spill.
Spill on hard surface
Restrict area of spill
Obtain drug spill kit
Put on protective gown, gloves, goggles
Open waste disposal bags
Place absorbent pads gently on the spill; be careful not to touch spill.
Place absorbent pad in waste bag
Cleanse surface with absorbent towels using detergent solution and wipe clean with clean tap water.
Place all contaminated materials in the bag.
Wash hands thoroughly with soap and water.
Spill on personnel or patient
Restrict area of spill
Obtain drug spill kit
Immediately remove contaminated protective garments or linen
Wash affected skin area with soap and water
If eye exposure-immediately flood the affected eye with water for at least 5 mts; obtain medical attention
promptly
Notify the physician if drug spills on patient.
Documentation- Document the spill.
-
8/2/2019 Drugs Associated With CANCER THERAPIES
29/32
VIII. Staff Education
All personnel involved in the care should receive an orientation to chemo. Drugs including their known risk ,
relevant techniques and procedures for handling, the proper use of protective equipment and materials, spill
procedures, and medical policies covering personnel handling chemo. agents.
Personnel handling blood, vomitus, or excreta from patients who have received chemotherapy should wear
disposable gloves and gowns to be appropriately discarded after use.
IX. Extravasation management
Extravasation is the accidental infiltration of vesicant or irritant chemotherapeutic drugs from the vein into
the surrounding tissues at the I/V site. A vesicant is an agent that can produce a blister and /or tissue
destruction. An irritant is an agent that is capable of producing venous pain at the site of and along the vein
with or without an inflammatory reaction. Injuries that may occur as a result of extravasation include
sloughing of tissue , infection, pain ,and loss of mobility of an extremity.
1.Prevention of extravasation
Nursing responsibilities for the prevention of extravasation include the following
Knowledge of drug s with vesicant potential
Skill in drug administration
Identification of risk factors e.g. multiple vene punctures
Anticipation of extravasation and knowledge of management protocol
New venepuncture site daily if peripheral access is used
Central venous access for 24 hrs vesicants infusion
Administration of drug in a quiet, unhurried environment
Testing vein patency without using chemotherapeutic agents
Providing adequate drug dilution
Careful observation of access site and extremity throughout the procedure
Ensuring blood return from I/V site before, during, and after vesicant drug infusion.
Educating patients regarding symptoms of drug infiltration , e.g. pain, burning, stinging sensation at I/V site.
2.Extravasation management at peripheral site-According to agency policy and approved antidote should
be readily available.
The following procedure should be initiated-
Stop the drug
Leave the needle or catheter in place
Aspirate any residual drug and blood in the I/V tubing, needle or catheter, and suspected infiltration site
Instill the I/V antidote
Remove the needle
If unable to aspirate the residual drug from the IV tubing , remove needle or catheter
Inject the antidote sub-cutaneously clockwise into the infiltrated site using 25 gauge needle; change the
needle with each new injection
Avoid applying pressure to the suspected infiltration site
Apply topical ointment if ordered
Cover lightly with an occlusive sterile dressing
Apply cold or warm compresses as indicated
Elevate the extremity
Observe regularly for pain, erythema, induration, and necrosis
-
8/2/2019 Drugs Associated With CANCER THERAPIES
30/32
Documentation of extravasation management.
All nursing personnel should be alert and prepared for the possible complication of anaphylaxis.
X. Nursing Management of common side effects of Chemotherapeutic drugs.
.Nausea & Vomiting
Nausea is the conscious recognition of the subconscious excitation of an area of the medulla closelyassociated with or part of the vomiting center. Nausea may cause the desire to vomit & it often precedes or
accompanies vomiting.
Avoid eating/drinking for 1-2 hrs prior to and after chemotherapy administration
Eat frequent, small meals. Avoid greasy & fatty foods and very sweet foods & candies.
Avoid unpleasant sights, odors & testes
Follow a clear liquid diet
If vomiting is severe inform the physician.
Consider diversionary activities
Sip liquids slowly or suck ice cubes and avoid drinking a large volume of water if vomiting is present
Administer antiemetics to prevent or minimize nausea. Patient may require routine antiemetics for 3-5 daysfollowing some protocols.
Monitor fluid and electrolyte status.
Provide frequent, systemic mouth care.
Bone marrow Depression This can lead to
-Anaemia
-Bleeding due to thrombocytopenia
-Infection due to leukopenia
Nursing Actions
Administer packed RBC according to the physician orders.
Monitor hematocrit and haemoglobin especially during drug nadir
Maintain the integrity of the skin
Avoid activities with the greatest potential for physical injury
Use an electric razor when shaving
Avoid the use of tourniquets
Eat a soft, bland diet, avoid foods that are thermally, mechanically and chemically irritating.
Maintain the integrity of the mucous membranes of G I tract
Promote hydrate to avoid constipation
Avoid enemas, harsh laxatives & the use of rectal thermometers.
Take steroids with an antacid or milk.
Avoid sources of infection
Maintain good personal hygiene.Prevent trauma to skin & mucous membranes
Report s/s of infection to physician
Monitor counts
Avoid invasive procedures, no
Raise the arm while pressure is applied after removal of a needle or catheter
-
8/2/2019 Drugs Associated With CANCER THERAPIES
31/32
Alopecia
Explain hair loss is temporary, and hair will grow when drug is stopped.
Use a mild, protein based shampoo, hair conditioner every 4-7 days
Minimize the use of an electric dyer.
Avoid excessive brushing and combing of the air. Combing with a wide tooth comb is preferred.
Select wig, cap, scarf or turban before hair loss occurs.
Keep head covered in summer to prevent sunburn and in winter to prevent heat loss.
Fatigue - Assess for possible causes chronic pain, stress, depression and in-sufficient rest or
nutritional intake.
-Conserve energy & rest when tired
-Plan for gradual accommodation of activities.
-Monitor dietary & fluid intake daily. Drink 3000 ml of fluid daily, unless contra-indicated, in order to avoid
the accumulation of cellular waste products.
Anorexia
Freshen up before meals
Avoid drinking fluids with meals to prevent feeling of fullness
High protein diet
Monitor and record weight weekly. Report weight loss
Stomatitis (Oral)
-Symptoms occur 5-7 days after chemotherapy & persist upto 10 days
-Continue brushing regularly with soft tooth brush
-Use non irritant mouthwash
-Avoid irritants to the mouth
-Maintain good nutritional intake, eat soft or liquid foods high in protein
Follow prescribed medication schedule e.g. drug for oral candidiasis.
-Report physician if symptom persists
-Increase the frequency of oral hygiene every 2 hrs
-Glycerin & lemon juice should never be used to clear mouth or teeth as it cause the tissues to become
dry& irritated.
Diarrhoea - Some clients experience diarrhoea during and after treatment with chemotherapy.
Nursing Action
Monitor number, frequency and consistency of diarrhoea stools.
Avoid eating high roughage, greasy and spicy food alcoholic beverages, tobacco and caffeine products
Avoid using milk products
Eat low residue diet high in protein and calories
Include food high in potassium if fatigue is present like bananas, baked potatoes.
Drink 3000 ml of fluid each day.Eat small frequent meals ; eat slowly and chew all food thoroughly
Clean metal area after each bowel movement.
Administer anti-diarrhoeal agents as prescribed.
Depression
Assess for changes in mood and affect.
Set small goals that are achievable daily
-
8/2/2019 Drugs Associated With CANCER THERAPIES
32/32
Participate e.g. music, reading, outings
Share feelings
Reassurance
Cystitis-
Is an inflammation of the bladder, which is usually caused by an infection. Sterile cystitis not induced by
infection. Sterile cystitis not induced by infection, can be a side effect of radiation therapy or due tocyclophosphamide (endoxan) administration. The metabolites of cyclophosphamide are excreted by the
kidneys in the urine
Nursing Actions
Fluid intake at least 3000 ml daily
Empty Bladder as soon as the urge to void is experienced.
Empty bladder at least every 2-4 hrs.
Urinate at bed time to avoid prolonged exposure of the bladder wall to the effects of cytoxan while sleeping.
Take oral cytoxan early in the morning to decrease the drug concentration in the bladder during the night
Report increasing symptoms of frequency bleeding burning on urination, pain fever and chills promptly to
physicianFollowing comfort measures can be adopted if cystitis is present
-Ensure dilute urine by increasing the fluid intake
Avoid foods & beverages that may cause irritation to the bladder alcohol, coffee, strong tea, Carbonated
beverages etc.
Outpatient Chemotherapy Delivery
Aggressive, complex and sophisticated cancer therapies are currently being in ambulatory & home care
settings. This shift is provision of services from the Hospital setting is a result o cost-containment efforts,
advanced technology, competition & increased competence of nurses.
Conclusion Chemotherapy offers patients with cancer a great deal of hope for a cure or a means of
control cancer for a long period of time. Hope and optimism are vital ingredients in care plan.
-Virgie-